A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pamela Freda, M.D
Columbia University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
63 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitätsklinikum Essen
Essen, Germany
- Universitätsklinikum Frankfurt, Medizinische Klinik 1, Schwerpunkt Endokrinologie, Diabetologie, Ernährungsmedizin
Frankfurt, Germany
- Universitätsklinikum Freiburg
Freiburg im Breisgau, Germany
- Lmu Clinic of University of Munich, Medical Clinic and Polyclinic Iv
Munich, Germany
- Medicover Neuroendokrinologie
Munich, Germany
- Medicover Oldenburg Mvz
Oldenburg, Germany
- Aretaeio University Hospital Endocrinology Department, Faculty of Diabetes and Metabolism
Athens, Greece
- General Hospital of Athens "laiko", Endocrinology University Clinic
Athens, Greece
- General Hospital of Thessaloniki "ippokratio"
Thessaloniki, Greece
- Military Healt Center, 2nd Department of Internal Medicine
Budapest, Hungary
- Szte Áok I.Sz. Belgyógyászati Klinika
Szeged, Hungary
- Irccs Policlinico San Martino
Genova, Italy
- Azienda Universitaria "federico Ii"
Naples, Italy
- Azienda Ospedaliera Padova, Department of Internal Medicine
Padova, Italy
- Policlinic Gemelli University Hospital Irccs, Department of Endocrinology
Roma, Italy
- Aoui Verona, Policlinic of Gb Rossi
Verona, Italy
- Centrum Nowoczesnych Terapii "dobry Lekarz"
Krakow, Poland
- Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie
Krakow, Poland
- Amicare Sp. Z O.O. Sp. K.
Lodz, Poland
- Piekarskie Centrum Medyczne, Szpital Miejski
Piekary Śląskie, Poland
- Interregional Clinical Diagnostic Center
Kazan', Russia
- "atlas" Medical Center
Moscow, Russia
- Sechenov Moscow First State Medical University
Moscow, Russia
- Vladimirsky Moscow Regional Research Clinical Institute
Moscow, Russia
- Novosibirsk State Regional Clinical Hospital
Novosibirsk, Russia
- Interregional Clinical Diagnostic Center
Ryazan, Russia
- Saratov Regional Clinic Hospital
Saratov, Russia
- University Hospital Complex A Coruña
A Coruña, Spain
- University Hospital of Alicante
Alicante, Spain
- Hospital Universitario Vall D'Hebron
Barcelona, Spain
- Hospital Universitario Gregorio Marañón
Madrid, Spain
- Hospital Universitario la Princesa
Madrid, Spain
- Complejo Hospitalario Universitario Santiago de Compostela
Santiago de Compostela, Spain
- University Hospital Virgen del Rocio
Seville, Spain
- Hospital Universitario de la Ribera
Valencia, Spain
- Hospital Universitario Y Politécnico la Fe
Valencia, Spain
- Akdeniz University Faculty of Medicine Department of Endocrinology
Antalya, Turkey (Türkiye)
- Aydın Adnan Menderes University Research and Application Hospital
Aydin, Turkey (Türkiye)
- Pamukkale University Faculty of Medicine Department of Endocrinology
Denizli, Turkey (Türkiye)
- Eskisehir Osmangazi University Medical Faculty
Eskişehir, Turkey (Türkiye)
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Aug 2019
- Primary completion
- 2 May 2023
- Completion
- 2 May 2023
- Last update posted
- 20 Aug 2026
- Registered enrollment
- 72
- Registry id
- NCT04076462
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.